We are forming a Joint Venture withTasly Pharmaceutical Group Co., LTD.to develop, manufacture, and commercialize Cellvizio for the Chinese market, with the goal of expanding our presence in a very significant way.
With this JV, we will also launch Cellvizio for the neurosurgery market globally .
In exchange of certain IP and licensing rights, Mauna Kea will receive cash payments of $10 million (€9.94 million), 44% of the JV and 5-year minimum purchase commitments.
This is a concrete step on our strategic repositioning announced back in December
Read the PR to learn more about the details of this significant partnership: https://hubs.la/Q01gzfQc0
Congrats to our great executive team and our excellent board members who all participated !
OIL Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
We are forming a Joint Venture with Tasly Pharmaceutical Group Co., LTD. to develop, manufacture, and commercialize Cellvizio for the Chinese market, with the goal of expanding our presence in a very significant way.
With this JV, we will also launch Cellvizio for the neurosurgery market globally .
In exchange of certain IP and licensing rights, Mauna Kea will receive cash payments of $10 million (€9.94 million), 44% of the JV and 5-year minimum purchase commitments.
This is a concrete step on our strategic repositioning announced back in December
Read the PR to learn more about the details of this significant partnership: https://hubs.la/Q01gzfQc0
Congrats to our great executive team and our excellent board members who all participated !